Jason M Reefer

February 16, 2015 | National Law Journal

A proposal by the Food and Drug Administration would expose drugmakers to personal-injury liability.

By Jason M. Reefer and Matthew R. Wendler

7 minute read

February 13, 2015 | National Law Journal

A proposal by the Food and Drug Administration would expose drugmakers to personal-injury liability.

By Jason M. Reefer and Matthew R. Wendler

7 minute read

February 10, 2015 | The Legal Intelligencer

Under the federal Food, Drug and Cosmetic Act, a drug is classified either as a branded drug (a drug whose composition is novel) or as a generic drug (a drug designed to be a copy of a branded drug). Manufacturers of the latter are currently immune from most products liability lawsuits. But this near-immunity may soon come to an end.

By Jason M. Reefer and Matthew R. Wendler

8 minute read

February 09, 2015 | The Legal Intelligencer

Under the federal Food, Drug and Cosmetic Act, a drug is classified either as a branded drug (a drug whose composition is novel) or as a generic drug (a drug designed to be a copy of a branded drug). Manufacturers of the latter are currently immune from most products liability lawsuits. But this near-immunity may soon come to an end.

By Jason M. Reefer and Matthew R. Wendler

8 minute read